Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CRVO compared with OKYO: revenue, margins and what each company keeps, and the suppliers and customers both name
CRVO
CervoMed Inc.
Change
Mkt cap
Revenue
Revenue
OKYO
OKYO Pharma Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
CRVO
CervoMed Inc.
vs
OKYO
OKYO Pharma Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
CRVO
CervoMed Inc.
Change
1.66
▲
+6.92%
Mkt cap
$24.8M
Revenue
$8,726
Q4 FY25
Revenue
$4M
FY25
OKYO
OKYO Pharma Ltd
Change
1.43
▼
−1.38%
Regular session
Nov 4 '26
Mkt cap
$76.6M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 4 '26
CRVO
CervoMed Inc.
vs
OKYO
OKYO Pharma Ltd
1.66
▲
+6.92%
Price
1.43
▼
−1.38%
$24.8M
Mkt cap
$76.6M
Q4 FY25
$8,726
Revenue
—
FY25
$4M
Revenue
—
Change
Change
CRVO
1.66
▲
+6.92%
vs
OKYO
1.43
▼
−1.38%
Regular session
Nov 4 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CRVO, solid
OKYO, dashed
Supply-chain overlap
Revenue flow
CRVO: latest quarter is a loss; flow not drawable. OKYO: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CRVO
3
VRTX
Vertex
supplier
—
NIA Grant
unlisted
supplier
—
NIA
unlisted
supplier
Shared
0
No shared counterparties.
Only OKYO
1
—
On Target Therapeutics
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR